Source:http://linkedlifedata.com/resource/pubmed/id/20166185
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2010-2-26
|
| pubmed:abstractText |
To monitor the prevalence of hepatitis B and hepatitis C a cross-sectional survey was conducted in 2004 among French metropolitan residents. A complex sampling design was used to enroll 14,416 adult participants aged 18-80 years. Data collected included demographic and social characteristics and risk factors. Sera were tested for anti-HCV, HCV-RNA, anti-HBc and HBsAg. Data were analyzed with SUDAAN software to provide weighted estimates for the French metropolitan resident population. The overall anti-HCV prevalence was 0.84% (95% CI: 0.65-1.10). Among anti-HCV positive individuals, 57.4% (95% CI: 43.2-70.5) knew their status. Factors associated independently with positive anti-HCV were drug use (intravenous and nasal), blood transfusion before 1992, a history of tattoos, low socioeconomic status, being born in a country where anti-HCV prevalence >2.5%, and age >29 years. The overall anti-HBc prevalence was 7.3% (95%: 6.5-8.2). Independent risk factors for anti-HBc were intravenous drug use, being a man who has sex with men, low socioeconomic status, a stay in a psychiatric facility or facility for the mentally disabled, <12 years of education, being born in a country where HBsAg prevalence >2%, age >29 and male sex. The HCV RNA and HBsAg prevalence were 0.53% (95% CI: 0.40-0.70) and 0.65% (95% CI: 0.45-0.93), respectively. Among HBsAg positive individuals, 44.8% (95% CI: 22.8-69.1) knew their status. Anti-HCV prevalence was close to the 1990s estimates whereas HBsAg prevalence estimate was greater than expected. Screening of hepatitis B and C should be strengthened and should account for social vulnerability.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1096-9071
|
| pubmed:author |
pubmed-author:AntonaDeniseD,
pubmed-author:CosteDominiqueD,
pubmed-author:Delarocque-AstagneauElisabethE,
pubmed-author:DesenclosJean-ClaudeJC,
pubmed-author:DuboisFrédericF,
pubmed-author:GiordanellaJean-PierreJP,
pubmed-author:GueguenRenéR,
pubmed-author:Le StratYannY,
pubmed-author:LeiserSandrineS,
pubmed-author:LemassonJean-MarieJM,
pubmed-author:MeffreChristineC,
pubmed-author:MeyerJean-FrançoisJF,
pubmed-author:SteinmetzJosianeJ,
pubmed-author:WarszawskiJosianeJ
|
| pubmed:copyrightInfo |
2010 Wiley-Liss, Inc.
|
| pubmed:issnType |
Electronic
|
| pubmed:volume |
82
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
546-55
|
| pubmed:meshHeading |
pubmed-meshheading:20166185-Adolescent,
pubmed-meshheading:20166185-Adult,
pubmed-meshheading:20166185-Aged,
pubmed-meshheading:20166185-Aged, 80 and over,
pubmed-meshheading:20166185-Cross-Sectional Studies,
pubmed-meshheading:20166185-Female,
pubmed-meshheading:20166185-France,
pubmed-meshheading:20166185-Hepatitis B,
pubmed-meshheading:20166185-Hepatitis B Antibodies,
pubmed-meshheading:20166185-Hepatitis B Surface Antigens,
pubmed-meshheading:20166185-Hepatitis C,
pubmed-meshheading:20166185-Hepatitis C Antibodies,
pubmed-meshheading:20166185-Humans,
pubmed-meshheading:20166185-Male,
pubmed-meshheading:20166185-Middle Aged,
pubmed-meshheading:20166185-Prevalence,
pubmed-meshheading:20166185-RNA, Viral,
pubmed-meshheading:20166185-Risk Factors,
pubmed-meshheading:20166185-Socioeconomic Factors,
pubmed-meshheading:20166185-Urban Population,
pubmed-meshheading:20166185-Young Adult
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
|
| pubmed:affiliation |
National Institute for Public Health Surveillance, Saint-Maurice, France.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|